Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Alan Arnette Climbs K2 in Support of Alzheimer’s Awareness and Fundraising Campaign
  • USA - English


News provided by

PAN Communications

May 14, 2014, 11:55 ET

Share this article

Share toX

Share this article

Share toX

Austin, Texas (PRWEB) May 14, 2014 -- Abila is pleased to announce it will sponsor world-renowned mountaineer and Alzheimer’s advocate Alan Arnette as he prepares to climb K2, arguably the world’s most difficult mountain to climb, to raise awareness and research funds for one of the world’s most difficult diseases. Two not-for-profits dedicated to Alzheimer’s research and education will benefit from the climb: Cure Alzheimer’s Fund (CAF) and UsAgainstAlzheimer’s (USA2). Abila will serve as the primary commercial sponsor for the K2 “Memories are Everything” climb.

Alzheimer’s disease is now the third leading cause of death in the U.S. after heart disease and cancer. By 2050 the number of American seniors who are cognitively impaired will rise to 15 million. Most startling is that a woman in her 60’s will have a one in six chance of developing Alzheimer’s. To put this in perspective, for breast cancer, it is one in 11. This epidemic also takes a devastating physical and emotional toll on the families who are left to care for those afflicted with this terrible disease. Today, for every $550 spent on treating Alzheimer’s, only $1 is actually spent on finding a cure. The actual cost of treatment is going up while research spending is going down. Thus, the K2 climb will seek to convey the urgency needed to address fighting the disease, both through the private and public sectors. Additionally, the underlying message of Arnette’s mission is that every individual can make a difference in the world.

“We are so excited to be working with Alan as he makes this amazing journey to bring awareness and raise funds to help find a cure for a disease which has affected so many families in this country,” said Krista Endsley, CEO, Abila. “Alan’s personal story, courage and commitment to this cause are truly an inspiration for all of us. Once we heard Alan’s remarkable story, we simply couldn’t imagine not helping him reach this goal.”

At 28,251 feet, K2 is the world’s second highest mountain. After several days of journeying from Islamabad, Arnette will reach K2 after a weeklong trek on the Baltoro Glacier. A successful professional speaker, Arnette has been on 35 major expeditions around the world since age 38, including summiting Mt. Everest in 2011 at age 54. He will begin trekking to K2 in June and will chronicle his progress on his website http://www.alanarnette.com/K2CureAlz.

“I’m truly grateful for the support of Abila for a cause that is extremely personal,” said Arnette. “Ever since my mother’s untimely passing from this awful disease, I have devoted my life to raising money for Alzheimer's research, caregiver support and raising general awareness through my passion of mountaineering. It’s my hope that this mission will further these goals and help eventually find a cure for this debilitating disease.”

A key component to Arnette’s fundraising centers around a peer-to-peer (P2P) fundraising campaign in conjunction with his climb of K2, titled “Memories are Everything.” P2P fundraising is one of the most social forms of fundraising. His climb and P2P fundraising campaign provide an opportunity for everybody to share his story (as well as their own), to donate and ultimately help change the outcomes of this disease. This is an extremely powerful way to raise money and awareness since the fundraisers themselves become the heroes of the story. Engaging supporters in this way helps further spread the word about the need for action in curing the disease and the campaign itself becomes a grassroots movement. Alan’s goal, with the support of Abila, is to raise $1 million dollars to help find a cure. To give, share and promote “Memories are Everything,” please visit: http://www.alanarnette.com/K2CureAlz.

About Abila
Abila with Avectra, now an Abila company, serves strategic leaders and managers in dynamic not-for-profit organizations, associations and government agencies with comprehensive membership management SaaS and software solutions. Organizations trust Abila to simplify and streamline accounting, donor and grant management and large scale fundraising processes so they can perform their best work and focus on delivering their unique mission. For Abila, it’s personal and backed by a team with more than 50 years of experience dedicated to helping organizations achieve their vision. For more information, please visit http://www.abila.com.

To learn more about Abila’s involvement with Alzheimer’s awareness through Alan’s cause, visit http://www.abila.com/Alzheimers.

Maribel Lopez, PAN Communications, http://www.abila.com, +1 (617) 502-4358, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.